Connect Biopharma Holdings Limited
CNTB
$2.12
-$0.08-3.64%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -19.40M | -15.11M | -17.20M | -12.90M | -10.27M |
| Total Depreciation and Amortization | 164.00K | 181.00K | 179.00K | 171.00K | 173.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.19M | 853.00K | 747.00K | 663.00K | 727.00K |
| Change in Net Operating Assets | 2.04M | 2.83M | -1.13M | -526.00K | -587.00K |
| Cash from Operations | -16.01M | -11.25M | -17.41M | -12.59M | -9.96M |
| Capital Expenditure | -- | -16.00K | -34.00K | -303.00K | -81.00K |
| Sale of Property, Plant, and Equipment | -- | 0.00 | 0.00 | 0.00 | 2.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 6.00M | 11.00M | 14.38M | 5.43M | -20.56M |
| Cash from Investing | 6.00M | 10.98M | 14.35M | 5.13M | -20.64M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 17.62M | 715.00K | 215.00K | 161.00K | 2.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 17.62M | 715.00K | 215.00K | 161.00K | 2.00K |
| Foreign Exchange rate Adjustments | 72.00K | 51.00K | 58.00K | 224.00K | 75.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7.69M | 500.00K | -2.79M | -7.08M | -30.52M |